| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |